{"JunBXVUAAAAJ": [["Michael D Cusimano", 2020, "Data Driven Analysis Reveals Shared Transcriptome Response, Immune Cell Composition, and Distinct Mortality Rates Across Differing Etiologies of Critical Illness"], ["Alexander Landry", 2020, "Data Driven Analysis Reveals Shared Transcriptome Response, Immune Cell Composition, and Distinct Mortality Rates Across Differing Etiologies of Critical Illness"], ["Michael Balas", 2020, "Data Driven Analysis Reveals Shared Transcriptome Response, Immune Cell Composition, and Distinct Mortality Rates Across Differing Etiologies of Critical Illness"], ["Zsolt Zador", 2020, "Data Driven Analysis Reveals Shared Transcriptome Response, Immune Cell Composition, and Distinct Mortality Rates Across Differing Etiologies of Critical Illness"], ["Lisa Burry", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Mike Clarke", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Jacques Lee", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Najma Siddiqi", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Valerie Page", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["John Marshall", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Louise Rose", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Noll Campbell", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["Meera Agar", 2020, "Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review"], ["JC Marshall", 2020, "Measuring organ dysfunction"], ["Karen EA Burns", 2020, "Three Decades of Collaboration in Critical Care Research"], ["Kevin Thorpe", 2020, "Three Decades of Collaboration in Critical Care Research"], ["Shujun Diana Yan", 2020, "Three Decades of Collaboration in Critical Care Research"], ["Zahra Bhimani", 2020, "Three Decades of Collaboration in Critical Care Research"], ["Marina Clement", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Sean P Collins", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["\u00c9tienne Gayat", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Eileen Rubin", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Samir Jaber", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Michael A Matthay", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Pierre-Fran\u00e7ois Laterre", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Rhonda E Monroe", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Michelle Ng Gong", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Wesley H Self", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Jonathan D Casey", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Alexandre Mebazaa", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Todd W Rice", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Michael O Harhay", 2020, "Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop"], ["Katrina J Sullivan", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Manoj Lalu", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Brent Winston", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Duncan J Stewart", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Claudia Dos Santos", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Mary Thompson", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Brian Hutton", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Shirley HJ Mei", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Dianna Wolfe", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Lauralyn McIntyre", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Dean Fergusson", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Alies Maybee", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Jos\u00e9e Champagne", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Keith R Walley", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["John Granton", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Emily Doxtator", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Shane W English", 2020, "Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"], ["Alison Fox-Robichaud", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Pedro Castelo-Branco", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Pingzhao Hu", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Patricia C Liaw", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Dhruva J Dwivedi", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Alexandra Binnie", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Jennifer LY Tsang", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Gabriela Carrasqueiro", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Jane Batt", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Christopher J Walsh", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Sahil Gupta", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Claudia C dos Santos", 2020, "Epigenetic Profiling in Severe Sepsis: A Pilot Study of DNA Methylation Profiles in Critical Illness"], ["Sharon O'Donoghue", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Jennifer P Stevens", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Julia K Sheehan", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Mudit Tandon", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Noah X Tocci", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Alyse M Reichheld", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Kelsey Hills-Evans", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["Douglas Hsu", 2019, "A national survey of approaches to manage the ICU patient with opioid use disorder"], ["John G Marshall", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Eleftherios P Diamandis", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Margaret Truc Ho", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Pete Bowden", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Philip Scheltens", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Tenzin Norzin", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Angelique Florentinus-Mefailoski", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Zhuo Zhen Chen", 2019, "The plasma peptides of breast versus ovarian cancer"], ["KWM Siu", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Alexander Romaschin", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Joep Killestein", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Morla Phan", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Amir Ravandi", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Jaimie Dufresne", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Thanusi Thavarajah", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Nargiz Mohamed", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Shawn Malone", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Christina Addison", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Daren Heyland", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Claudia C Dos Santos", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Eric Stanton", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Charlotte Teunissen", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Monika Tucholska", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Arthur S Slutsky", 2019, "The plasma peptides of breast versus ovarian cancer"], ["Rosemary Carroll", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Ernest E Moore", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Fausto Catena", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Luca Ansaloni", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Matti Tolonen", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Fikri M Abu-Zidan", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Massimo Sartelli", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Peter D Faris", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Jose J Diaz", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Christopher J Doig", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Stacey A Page", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Bruno M Peirera", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Andrew W Kirkpatrick", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Federico Cocolini", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Jessica L McKee", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Sam F Minor", 2019, "Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis"], ["Emmanuel Charbonney", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Michael K Xu", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Nicholas L Jackson Chornenki", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Robert Coke", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Andrew C Kwong", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Ellen McDonald", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Alison E Fox-Robichaud", 2019, "Comparison of the source and prognostic utility of cfDNA in trauma and sepsis"], ["Richard A Veldhoen", 2019, "Insights Into a \u201cNegative\u201d ICU Trial Derived From Gene Expression Profiling"], ["John Muscedere", 2019, "Insights Into a \u201cNegative\u201d ICU Trial Derived From Gene Expression Profiling"], ["David M Maslove", 2019, "Insights Into a \u201cNegative\u201d ICU Trial Derived From Gene Expression Profiling"], ["Mary Hoekstra", 2019, "Insights Into a \u201cNegative\u201d ICU Trial Derived From Gene Expression Profiling"], ["St\u00e9phane Gagnon", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Brian P Kavanagh", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Razieh Rabani", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Gail Otulakowski", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Mirjana Jerkic", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Taylor Ward-Able", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Claire Masterson", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["John G Laffey", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Gerard F Curley", 2019, "Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats."], ["Sachin Yende", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Theodore J Iwashyna", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Cheryl Misak", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Flavia R Machado", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Simon Finfer", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Ramona O Hopkins", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Bronagh Blackwood", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Linda L Chlan", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Carol Hodgson", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Pinaki Panigrahi", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Catherine L Hough", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Konrad Reinhart", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["James C Jackson", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Derek C Angus", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Ross Zafonte", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Hallie C Prescott", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Timothy D Girard", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Thierry Calandra", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Kathryn M Rowan", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Luigi Ferrucci", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Dale M Needham", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Paul Dark", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Bronwen Connolly", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Karen Choong", 2019, "Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice"], ["Suzanne Ringrow", 2019, "A core outcome set for critical care ventilation trials"], ["Daniel F McAuley", 2019, "A core outcome set for critical care ventilation trials"], ["Leslie M Chu", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Leslie Chu", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["RECOVER Program Investigators", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Lianne Singer", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Matteo Parotto", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Vincent Lo", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["George Tomlinson", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Niall Ferguson", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Mark Bayley", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["M Elizabeth Wilcox", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Claudia dos Santos", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Robert Fowler", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Brian H Cuthbertson", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Paul Hebert", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Eddy Fan", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Najib Ayas", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Jill C Rudkowski", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Denise Morris", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Sangeeta Mehta", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Margaret Herridge", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Linda Flockhart", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Tasnim Sinuff", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Hilary Meggison", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Melanie Levasseur", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Priscila Robles", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Deborah Cook", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Adrienne Tan", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Neill KJ Adhikari", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Jill Cameron", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Sunita Mathur", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Andrea Matte", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Christie M Lee", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Francois Lamontagne", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Damon C Scales", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Shaf Keshavjee", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Marcelo Cypel", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Laurent Brochard", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Claire Thomas", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Cecelia Chaparro", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Susan E Abbey", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Margaret S Herridge", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Chung-Wai Chow", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Jill I Cameron", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Stacey Burns", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Yoanna Skrobik", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Mika Hamilton", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Linda Chan", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["John Flannery", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Jan O Friedrich", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Niall D Ferguson", 2019, "Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of\u2265 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis \u2026"], ["Robin Lemmens", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["ESO Trials Network Committee ESOTA Steering Group", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Urs Fischer", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Rustam A Salman", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Diederik WJ Dippel", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Peter Kelly", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Gary A Ford", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Anita Arsovska", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Christian Weimar", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Thompson Robinson", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Paul J Nederkoorn", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Blanca Fuentes", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["Eivind Berge", 2019, "Building a European \u2018network of networks\u2019 for stroke clinical research\u2013The European Stroke Organisation Trials Alliance (ESOTA)"], ["David SY Ong", 2016, "External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome"], ["Marcus J Schultz", 2016, "External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome"], ["Lieuwe D Bos", 2016, "External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome"], ["Laura R Schouten", 2016, "External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome"], ["Olaf L Cremer", 2016, "External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome"], ["Jennie Johnstone", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Maureen Meade", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Peter M Dodek", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Yaseen Arabi", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Tim Karachi", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["William Henderson", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Diane Heels-Ansdell", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Deborah J Cook", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Michael G Surette", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Chris P Verschoor", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Robert W Taylor", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["PROSPECT Investigators", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Canadian Critical Care Trials Group", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Francois Lauzier", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Lehana Thabane", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Eyal Golan", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Gordon Wood", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Daniel Ovakim", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Joe Pagliarello", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Daphnee Lamarche", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Erick H Duan", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Rodrigo Cartin-Ceba", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Dawn ME Bowdish", 2016, "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial\u2014PROSPECT: a pilot trial"], ["Sean Keenan", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Andre CKB Amaral", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Gordon D Rubenfeld", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Daniel Roberts", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Greg Martinka", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Anand Kumar", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Denny Laporta", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Ruxandra Pinto", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Paul Ellis", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Robert A Fowler", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Brian Bookatz", 2016, "Patient and organizational factors associated with delays in antimicrobial therapy for septic shock"], ["Mohit Kapoor", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Jiafeng Wang", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Elizabeth M Johnson", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Chan-Mi Lee", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Jim Hu", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Leslie J Crofford", 2016, "Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts"], ["Mathias Schroedter", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Etienne Gayat", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Roger J Lewis", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Oliver Hartmann", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Frauke Hein", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Greet Van den Berghe", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Anne Louise Kjolbye", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Matthieu Legrand", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Peter Radermacher", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Pierre Fran\u00e7ois Laterre", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Paul Scigalla", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Joachim Struck", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Mehmet Birhan Yilmaz", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Wendy Gattis Stough", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Luciano Gattinoni", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Gernot Marx", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Andreas Bergmann", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["James A Russell", 2016, "Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure"], ["Jesse W Delaney", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Jennifer Long", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Fran\u00e7ois Lamontagne", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Neill K Adhikari", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Lisa D Burry", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Jamie Hutchison", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Kusum Menon", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Philippe Jouvet", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Canadian Critical Care Trials Group H1N1 Collaborative", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Donald Griesdale", 2016, "The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness"], ["Renato D Lopes", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Anne Holbrook", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Mitchell AH Levine", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Stephen D Walter", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Guowei Li", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Noori Akhtar-Danesh", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Rob Taylor", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Peter Dodek", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Dean Chittock", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Gordon Guyatt", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Yaseen M Arabi", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["Andreas P Freitag", 2016, "Risk factors for and prediction of mortality in critically ill medical\u2013surgical patients receiving heparin thromboprophylaxis"], ["David Moher", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["Mazen Jazi", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["Manoj M Lalu", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["Alexander Straus", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["Dean A Fergusson", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["Malcolm MacLeod", 2016, "Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial"], ["SJ Winston", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Mardh", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Berkius", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["G Maclaren", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["B Bissett", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Kot", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Shander", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["BA Harris", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["F Philippart", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Barr", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Hadem", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Mormon", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["ARDSNet", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Thomas", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Bagai", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["JF McCarthy", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["K Weber", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["B Connolly", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["JM Edwards", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["T Nolin", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Galderisi", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["RM Kacmarek", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["N Bottino", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["PJ Andrews", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["VY Reddy", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Nielsen", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Combes", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["RS Hotchkiss", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["DA Harrison", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["F Lu", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Singer", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Davey", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["F Lauzier", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Zinger", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Cheron", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["L Mill", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Thooft", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["JC Plana", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Phua", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Steier", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MP Fink", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Barac", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Sinderby", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["E Deland", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["PS Douglas", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Z Al Aseri", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["D McWilliams", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Mongodi", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Bonadona", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["RH Bartlett", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["K Isabella", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["KM Kaukonen", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Zobel", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["CW Seymour", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["GD Murray", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Kuehn", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["L Boudourakis", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["TJ Bunch", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Bailey", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["R Driessen", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Y Madhu Reddy", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Weblin", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Nolan", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Douiri", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["NBT Lin", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Bassily-Marcus", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["K See", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["AS Sharma", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["CR Harber", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["DF McAuley", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["TSR Delnoij", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Ebidia", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["L Potton", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Le Neindre", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Davidson", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Alansari", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Hutchinson", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Loveridge", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["P Stammet", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["CM O'Kane", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Wahab", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["DE Haines", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["T Langer", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["TC Horan", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["F Fay", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Leech", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MM Levy", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Doymaz", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["H Cohen", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["V Ong", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Muscedere", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["JC Preiser", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["SM Eldridge", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["O Collignon", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Mahapatra", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Suzuki", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Batchinsky", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MJ Garcia", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["RM Hegde", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Simmonds", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Rosenkranz", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["P Thavendiranathan", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MJ Kallan", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Wood", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["D Needham", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["F Longhini", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["K Wright", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["TV Dela Cruz", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["P Navalesi", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Stub", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["DF Gaieski", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["G Atkins", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["JK Muhammad", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Minet", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["G Chanques", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MT McEvoy", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["BD Freeman", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["V Kasirajan", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Wong", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Hassager", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["E Major", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Huntgeburth", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["C Adler", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["KJ Sosnowski", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["AR Brady", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["T Fuehner", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["S Spence", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["T Sweberg", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["A Santini", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MJ Wildman", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["NG Smedira", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["MK Greene", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Auzinger", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["D Young", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["D Stewart", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["M Chikhani", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["H Alotair", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Blanco", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["J Villar", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["CS Deutschman", 2016, "Assessing and combining repeated prognosis of physicians and temporal models in the intensive care"], ["Mohammed Alshahrani", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Adam M Deane", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Diane Heel-Ansdell", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Bram Rochwerg", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Nicole Zytaruk", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Waleed Alhazzani", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Nick Daneman", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Richard Hall", 2016, "Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial"], ["Faisal Siddiqui", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DM Yealy", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DK Stapleton", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["E Rivers", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DT Huang", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["A Delaney", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["SL Peake", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["S Havstad", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["SG Simonson", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["JA Kellum", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DC Angus", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DR Hill", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["B Nguyen", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["RD Grieve", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["A Barnato", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["J Ressler", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["S Finfer", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["A Muzzin", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["RP Dellinger", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["LA Weissfeld", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["PS Barie", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["B Knoblich", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["PR Mouncey", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["A Artigas", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["JF Bion", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["DS Newburg", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["IS Douglas", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["GS Power", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["D Bell", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["TM Osborn", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["R Jahan", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["VM Ranieri", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["Daniel Smith", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["PROWESS-SHOCK Study Group", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["Brijesh Patel", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["R Malik", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["JF Dhainaut", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["ProMISe Trial Investigators", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["M Tomlanovich", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["JL Vincent", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["K Guntupalli", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["A Rhodes", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["ProCESS/ARISE/ProMISe Methodology Writing Committee", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["B G\u00e5rdlund", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["E Peterson", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["SR Gunn", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["BT Thompson", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["Oral tAlactoferrin in Severe sepsIS Study Investigators", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["MZ Sadique", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["SE Harvey", 2016, "Drotrecogin alfa (activated) in adults with septic shock"], ["Sergio Canestrini", 2016, "Trauma and endothelial glycocalyx: the microcirculation helmet?"], ["Mazin Tuma", 2016, "Trauma and endothelial glycocalyx: the microcirculation helmet?"], ["Zeina Alwahab", 2016, "Trauma and endothelial glycocalyx: the microcirculation helmet?"], ["Fran\u00e7ois Lauzier", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Sean M Bagshaw", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Rachel D Savage", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Henry T Stelfox", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Claudio M Martin", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Asgar H Rishu", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["Steven Reynolds", 2016, "Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study"], ["N Fletcher", 2016, "ESICM LIVES 2016: part one"], ["JR Masclans", 2016, "ESICM LIVES 2016: part one"], ["O Cremer", 2016, "ESICM LIVES 2016: part one"], ["T van der Poll", 2016, "ESICM LIVES 2016: part one"], ["O Tucker", 2016, "ESICM LIVES 2016: part one"], ["C Climent", 2016, "ESICM LIVES 2016: part one"], ["MO Pozo", 2016, "ESICM LIVES 2016: part one"], ["D Shilkin", 2016, "ESICM LIVES 2016: part one"], ["A Taggu", 2016, "ESICM LIVES 2016: part one"], ["B Balsera Garrido", 2016, "ESICM LIVES 2016: part one"], ["J Lipman", 2016, "ESICM LIVES 2016: part one"], ["AM Dondorp", 2016, "ESICM LIVES 2016: part one"], ["A Torres", 2016, "ESICM LIVES 2016: part one"], ["R Schweizer", 2016, "ESICM LIVES 2016: part one"], ["S Rehberg", 2016, "ESICM LIVES 2016: part one"], ["C Canull\u00e1n", 2016, "ESICM LIVES 2016: part one"], ["T Pham", 2016, "ESICM LIVES 2016: part one"], ["N \u00d6veges", 2016, "ESICM LIVES 2016: part one"], ["MG Buscetti", 2016, "ESICM LIVES 2016: part one"], ["D Ong", 2016, "ESICM LIVES 2016: part one"], ["RS Parker", 2016, "ESICM LIVES 2016: part one"], ["N Campillo", 2016, "ESICM LIVES 2016: part one"], ["L Charris-Castro", 2016, "ESICM LIVES 2016: part one"], ["M Cecconi", 2016, "ESICM LIVES 2016: part one"], ["S Carvalho Brugger", 2016, "ESICM LIVES 2016: part one"], ["A Guti\u00e9rrez-Pizarraya", 2016, "ESICM LIVES 2016: part one"], ["M Gr\u00fcndling", 2016, "ESICM LIVES 2016: part one"], ["W Fornier", 2016, "ESICM LIVES 2016: part one"], ["PA Howells", 2016, "ESICM LIVES 2016: part one"], ["B Tudor", 2016, "ESICM LIVES 2016: part one"], ["D \u00c9rces", 2016, "ESICM LIVES 2016: part one"], ["J Trujillano Cabello", 2016, "ESICM LIVES 2016: part one"], ["J Neidecker", 2016, "ESICM LIVES 2016: part one"], ["M Jacquet-Lagr\u00e8ze", 2016, "ESICM LIVES 2016: part one"], ["LR Schouten", 2016, "ESICM LIVES 2016: part one"], ["KS Kim", 2016, "ESICM LIVES 2016: part one"], ["E Martins", 2016, "ESICM LIVES 2016: part one"], ["V Gusarov", 2016, "ESICM LIVES 2016: part one"], ["K Hahnenkamp", 2016, "ESICM LIVES 2016: part one"], ["K T\u00e1nczos", 2016, "ESICM LIVES 2016: part one"], ["N Darang", 2016, "ESICM LIVES 2016: part one"], ["J Horn", 2016, "ESICM LIVES 2016: part one"], ["JF Caminos Eguillor", 2016, "ESICM LIVES 2016: part one"], ["B Maitre", 2016, "ESICM LIVES 2016: part one"], ["JL Fellahi", 2016, "ESICM LIVES 2016: part one"], ["I L\u00e1szl\u00f3", 2016, "ESICM LIVES 2016: part one"], ["T Whitehouse", 2016, "ESICM LIVES 2016: part one"], ["M Samper", 2016, "ESICM LIVES 2016: part one"], ["N de Prost", 2016, "ESICM LIVES 2016: part one"], ["B Scicluna", 2016, "ESICM LIVES 2016: part one"], ["J Kaszaki", 2016, "ESICM LIVES 2016: part one"], ["F Gao", 2016, "ESICM LIVES 2016: part one"], ["G Jimenez Jimenez", 2016, "ESICM LIVES 2016: part one"], ["A Serpa Neto", 2016, "ESICM LIVES 2016: part one"], ["JI Ko", 2016, "ESICM LIVES 2016: part one"], ["G Carteaux", 2016, "ESICM LIVES 2016: part one"], ["E Festic", 2016, "ESICM LIVES 2016: part one"], ["DP Park", 2016, "ESICM LIVES 2016: part one"], ["C Fuchs", 2016, "ESICM LIVES 2016: part one"], ["HS Canales", 2016, "ESICM LIVES 2016: part one"], ["F Pike", 2016, "ESICM LIVES 2016: part one"], ["L van Vught", 2016, "ESICM LIVES 2016: part one"], ["M Lilot", 2016, "ESICM LIVES 2016: part one"], ["L Muller", 2016, "ESICM LIVES 2016: part one"], ["R Mu\u00f1oz-Berm\u00fadez", 2016, "ESICM LIVES 2016: part one"], ["F Barcenilla Gaite", 2016, "ESICM LIVES 2016: part one"], ["Y Corcia-Palomo", 2016, "ESICM LIVES 2016: part one"], ["I Martin-Loeches", 2016, "ESICM LIVES 2016: part one"], ["X Nuvials Casals", 2016, "ESICM LIVES 2016: part one"], ["M Ferrer", 2016, "ESICM LIVES 2016: part one"], ["L Brochard", 2016, "ESICM LIVES 2016: part one"], ["P Portran", 2016, "ESICM LIVES 2016: part one"], ["G Leb\u00e1k", 2016, "ESICM LIVES 2016: part one"], ["M Vollmer", 2016, "ESICM LIVES 2016: part one"], ["K van de Groep", 2016, "ESICM LIVES 2016: part one"], ["G Ferrara", 2016, "ESICM LIVES 2016: part one"], ["L Schouten", 2016, "ESICM LIVES 2016: part one"], ["JY Lefrant", 2016, "ESICM LIVES 2016: part one"], ["C Roger", 2016, "ESICM LIVES 2016: part one"], ["V Sara", 2016, "ESICM LIVES 2016: part one"], ["L Elotmani", 2016, "ESICM LIVES 2016: part one"], ["LD Bos", 2016, "ESICM LIVES 2016: part one"], ["K Kim", 2016, "ESICM LIVES 2016: part one"], ["M Vallverd\u00fa Vidal", 2016, "ESICM LIVES 2016: part one"], ["A Modler", 2016, "ESICM LIVES 2016: part one"], ["W Huber", 2016, "ESICM LIVES 2016: part one"], ["M Wiewel", 2016, "ESICM LIVES 2016: part one"], ["S Grasso", 2016, "ESICM LIVES 2016: part one"], ["JH Shin", 2016, "ESICM LIVES 2016: part one"], ["DR Thickett", 2016, "ESICM LIVES 2016: part one"], ["Z Moln\u00e1r", 2016, "ESICM LIVES 2016: part one"], ["M Riche", 2016, "ESICM LIVES 2016: part one"], ["J Laffey", 2016, "ESICM LIVES 2016: part one"], ["N Juffermans", 2016, "ESICM LIVES 2016: part one"], ["A Gabarrus", 2016, "ESICM LIVES 2016: part one"], ["VS Kanoore Edul", 2016, "ESICM LIVES 2016: part one"], ["C Brun-Buisson", 2016, "ESICM LIVES 2016: part one"], ["M N\u00e9meth", 2016, "ESICM LIVES 2016: part one"], ["FD Simonis", 2016, "ESICM LIVES 2016: part one"], ["J Frencken", 2016, "ESICM LIVES 2016: part one"], ["G Bellani", 2016, "ESICM LIVES 2016: part one"], ["GD Perkins", 2016, "ESICM LIVES 2016: part one"], ["M Bonten", 2016, "ESICM LIVES 2016: part one"], ["F Alvarez-Lerma", 2016, "ESICM LIVES 2016: part one"], ["A Dubin", 2016, "ESICM LIVES 2016: part one"], ["S Grau Cerrato", 2016, "ESICM LIVES 2016: part one"], ["A Giangregorio", 2016, "ESICM LIVES 2016: part one"], ["L Bos", 2016, "ESICM LIVES 2016: part one"], ["E Fernandez-Delgado", 2016, "ESICM LIVES 2016: part one"], ["D Tr\u00e1sy", 2016, "ESICM LIVES 2016: part one"], ["M Miralb\u00e9s Torner", 2016, "ESICM LIVES 2016: part one"], ["R Mendez", 2016, "ESICM LIVES 2016: part one"], ["A Hoogendijk", 2016, "ESICM LIVES 2016: part one"], ["D Swigon", 2016, "ESICM LIVES 2016: part one"], ["D Verboom", 2016, "ESICM LIVES 2016: part one"], ["E Fan", 2016, "ESICM LIVES 2016: part one"], ["GJ Suh", 2016, "ESICM LIVES 2016: part one"], ["A Escoresca-Ortega", 2016, "ESICM LIVES 2016: part one"], ["E Prina", 2016, "ESICM LIVES 2016: part one"], ["MJ Schultz", 2016, "ESICM LIVES 2016: part one"], ["C Knox", 2016, "ESICM LIVES 2016: part one"], ["C Ince", 2016, "ESICM LIVES 2016: part one"], ["G Clermont", 2016, "ESICM LIVES 2016: part one"], ["WY Kwon", 2016, "ESICM LIVES 2016: part one"], ["RM Grounds", 2016, "ESICM LIVES 2016: part one"], ["A Urbano", 2016, "ESICM LIVES 2016: part one"], ["OT Ranzani", 2016, "ESICM LIVES 2016: part one"], ["R Menendez", 2016, "ESICM LIVES 2016: part one"], ["L Pisani", 2016, "ESICM LIVES 2016: part one"], ["HD Aya", 2016, "ESICM LIVES 2016: part one"], ["C Scheer", 2016, "ESICM LIVES 2016: part one"], ["M Palomar Mart\u00ednez", 2016, "ESICM LIVES 2016: part one"], ["S Luque", 2016, "ESICM LIVES 2016: part one"], ["M Koster-Brouwer", 2016, "ESICM LIVES 2016: part one"], ["J Garnacho-Montero", 2016, "ESICM LIVES 2016: part one"], ["JA Roberts", 2016, "ESICM LIVES 2016: part one"], ["A Mekontso Dessap", 2016, "ESICM LIVES 2016: part one"], ["G Murias", 2016, "ESICM LIVES 2016: part one"], ["C Cilloniz", 2016, "ESICM LIVES 2016: part one"], ["LA Zhang", 2016, "ESICM LIVES 2016: part one"], ["F Vasco", 2016, "ESICM LIVES 2016: part one"], ["JP Roozeman", 2016, "ESICM LIVES 2016: part one"], ["SM Van der Hoeven", 2016, "ESICM LIVES 2016: part one"], ["A Ceccato", 2016, "ESICM LIVES 2016: part one"], ["A Mercat", 2016, "ESICM LIVES 2016: part one"], ["SO Kuhn", 2016, "ESICM LIVES 2016: part one"], ["M Schultz", 2016, "ESICM LIVES 2016: part one"], ["Andej Michalsen", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Stephen Jacobe", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Claudio Martin", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Paolo Pelosi", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["John Myburgh", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Fayez Abillama", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Davide Chiumello", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Ruth Kleinpell", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Lluis Blanch Torra", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Jean-Louis Vincent", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Janice Zimmerman", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Geoff Dobb", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Younsuk Koh", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Susan Yeager", 2016, "End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine"], ["Alasdair Gray", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Ian Stiell", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Alexis Turgeon", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Brian H Rowe", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Anders Perner", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Timothy S Walsh", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Robert Green", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Anthony Gordon", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Irwin Schweitzer", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Ryan Zarychanski", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Shane English", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Micha\u00ebl Chass\u00e9", 2016, "Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock"], ["Shawn J Wood", 2016, "Skyrocketing Drug Costs: Beyond the News and into Your Intensive Care Unit"], ["J Marshall", 2016, "MODS: THE ROLE OF THE DOCTOR"], ["Amanda McFarlan", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Timothy Rice", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Dave Paskar", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Sandro Rizoli", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Najma Ahmed", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Bernard Lawless", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Joao Neto", 2016, "Development and implementation of quality indicators for acute care surgery."], ["Yasser Sakr", 2016, "The Richmond Agitation-Sedation Scale should not be used to evaluate neurologic function"], ["Rui P Moreno", 2016, "The Richmond Agitation-Sedation Scale should not be used to evaluate neurologic function"], ["Jukka Takala", 2016, "The Richmond Agitation-Sedation Scale should not be used to evaluate neurologic function"], ["Adam Deane", 2016, "Stress ulcer prophylaxis in critical illness: a Canadian survey"], ["Jeffrey Barletta", 2016, "Stress ulcer prophylaxis in critical illness: a Canadian survey"], ["Mark Duffett", 2016, "Stress ulcer prophylaxis in critical illness: a Canadian survey"], ["Salmaan Kanji", 2016, "Stress ulcer prophylaxis in critical illness: a Canadian survey"], ["Melissa Shears", 2016, "Stress ulcer prophylaxis in critical illness: a Canadian survey"], ["Paul H\u00e9bert", 2016, "One-year outcomes in caregivers of critically ill patients"], ["Cecilia Chaparro", 2016, "One-year outcomes in caregivers of critically ill patients"], ["Alexis F Turgeon", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Michael Rudnicki", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Marc T Avey", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Gilly Griffin", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Malcolm Macleod", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Shirley H Mei", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Katrina Sullivan", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Jeremy M Grimshaw", 2016, "An Analysis Of Reporting According To The ARRIVE (Animal Research: Reporting Of In Vivo Experiments) Guidelines For Pre-Clinical Studies Of Mesenchymal Stromal Cells For The \u2026"], ["Jennifer Tsang", 2016, "Heat Shock Protein 90 (HSP90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (TLR-4) To Prolong Polymorphonuclear Neutrophil (PMN) Survival And Regulate \u2026"], ["Hajera Amatullah", 2016, "Heat Shock Protein 90 (HSP90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (TLR-4) To Prolong Polymorphonuclear Neutrophil (PMN) Survival And Regulate \u2026"], ["Robert D'Cruz", 2016, "Heat Shock Protein 90 (HSP90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (TLR-4) To Prolong Polymorphonuclear Neutrophil (PMN) Survival And Regulate \u2026"], ["Songhui Jia", 2016, "Heat Shock Protein 90 (HSP90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (TLR-4) To Prolong Polymorphonuclear Neutrophil (PMN) Survival And Regulate \u2026"], ["Emily Pearsall", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Jonathan Hsu", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Joshua A Greenberg", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Mohammad Bawazeer", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Robin S McLeod", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Gary R May", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Natalie Coburn", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Avery Nathens", 2016, "Clinical practice guideline: management of acute pancreatitis"], ["Stefan Ru\u00dfwurm", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Matthias Kohl", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Andriy Ruryk", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Andreas Kortgen", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Eva M\u00f6ller", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Evangelos J Giamarellos-Bourboulis", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Jean Marc Cavaillon", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Orlando Guntinas-Lichius", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Michael Bauer", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Britta Wlotzka", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Olivier Rutschmann", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Karen Felsmann", 2016, "A transcriptomic biomarker to quantify systemic inflammation in sepsis\u2014a prospective multicenter phase II diagnostic study"], ["Kamya Kommaraju", 2016, "Determinants of citation impact in large clinical trials in critical care: the role of investigator-led clinical trials groups"], ["Wilson Kwong", 2016, "Determinants of citation impact in large clinical trials in critical care: the role of investigator-led clinical trials groups"], ["Hernando Gomez", 2016, "Immune cell phenotype and function in sepsis"], ["John A Kellum", 2016, "Immune cell phenotype and function in sepsis"], ["Vincenzo Cantaluppi", 2016, "Immune cell phenotype and function in sepsis"], ["Patrick Murray", 2016, "Immune cell phenotype and function in sepsis"], ["Alonso Gomez", 2016, "Immune cell phenotype and function in sepsis"], ["Thomas Rimmel\u00e9", 2016, "Immune cell phenotype and function in sepsis"], ["Didier Payen", 2016, "Immune cell phenotype and function in sepsis"], ["Clifford S Deutschman", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Mervyn Singer", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Manu Shankar-Hari", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Rinaldo Bellomo", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Craig M Coopersmith", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Richard S Hotchkiss", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Jean-Daniel Chiche", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Gordon R Bernard", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Greg S Martin", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Tom van der Poll", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Steven M Opal", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Christopher Warren Seymour", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Djillali Annane", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["Mitchell M Levy", 2016, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)"], ["J Hsu", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["H Huang", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["M Bawazeer", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["N Coburn", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["JA Greenberg", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["JO Friedrich", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["A Nathens", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["RS McLeod", 2016, "Compliance with evidence-based guidelines in acute pancreatitis: an audit of practices in University of Toronto hospitals"], ["Yangmei Li", 2016, "Endotoxemia following multiple trauma: risk factors and prognostic implications"], ["Patricia Duque", 2016, "Endotoxemia following multiple trauma: risk factors and prognostic implications"], ["David Klein", 2016, "Endotoxemia following multiple trauma: risk factors and prognostic implications"], ["Jennifer Y Tsang", 2016, "Endotoxemia following multiple trauma: risk factors and prognostic implications"], ["Steve Reynolds", 2016, "Duration of antimicrobial treatment for bacteremia in Canadian critically ill patients"], ["Wei Xiong", 2016, "Duration of antimicrobial treatment for bacteremia in Canadian critically ill patients"], ["D Phil", 2016, "One-Year Outcomes in Caregivers of Critically Ill Patients"], ["Claudia Santos", 2016, "One-Year Outcomes in Caregivers of Critically Ill Patients"], ["C Thomas", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["JI Cameron", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["M Levasseur", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["F Lamontagne", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["S Mehta", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["G Tomlinson", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["L Chan", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["LM Chu", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["A Matte", 2016, "et a/.; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients"], ["AF Turgeon", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["M Rudnicki", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["MT Avey", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["B Hutton", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["SH Mei", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["L McIntyre", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["G Griffin", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["D Moher", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["K Sullivan", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["M Macleod", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["MM Lalu", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["DJ Stewart", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["D Fergusson", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["JM Grimshaw", 2016, "C49 RESPIRATORY FAILURE: CLINICAL AND TRANSLATIONAL ASPECTS OF VILI AND LUNG PROTECTIVE MV: An Analysis Of Reporting According To The Arrive (animal Research: Reporting Of In \u2026"], ["H Amatullah", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["R D'Cruz", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["C Dos Santos", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["S Gupta", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["J Tsang", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["S Jia", 2016, "A104 CRITICAL CARE: SEPSIS TRANSLATIONAL INSIGHTS: Heat Shock Protein 90 (hsp90) Stabilizes A Molecular Complex Of Caspase-8 And Toll-Like Receptor-4 (tlr-4) To Prolong \u2026"], ["D Hsu", 2016, "B22 BURDEN OF PULMONARY AND CRITICAL CARE MEDICINE: COST AND UTILIZATION: Trends In Heroin-And Prescription Opioid-Related Intensive Care Unit Admissions Between 2008-2014"], ["JP Stevens", 2016, "B22 BURDEN OF PULMONARY AND CRITICAL CARE MEDICINE: COST AND UTILIZATION: Trends In Heroin-And Prescription Opioid-Related Intensive Care Unit Admissions Between 2008-2014"], ["J Bertone", 2016, "B22 BURDEN OF PULMONARY AND CRITICAL CARE MEDICINE: COST AND UTILIZATION: Trends In Heroin-And Prescription Opioid-Related Intensive Care Unit Admissions Between 2008-2014"], ["S O'Donoghue", 2016, "B22 BURDEN OF PULMONARY AND CRITICAL CARE MEDICINE: COST AND UTILIZATION: Trends In Heroin-And Prescription Opioid-Related Intensive Care Unit Admissions Between 2008-2014"], ["A Law", 2016, "B22 BURDEN OF PULMONARY AND CRITICAL CARE MEDICINE: COST AND UTILIZATION: Trends In Heroin-And Prescription Opioid-Related Intensive Care Unit Admissions Between 2008-2014"], ["C Previtali", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Daniele Crespi", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Daniele Poole", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Guido Bertolini", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Martin Langer", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["C Rossi", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["M Tavola", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["M Mondini", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Giovanni Nattino", 2016, "The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experience"], ["Canadian Critical Care Translational Biology Group", 2016, "The devil is in the details: incomplete reporting in preclinical animal research"], ["Katalin Szaszi", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Pamela Plant", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Song Hui Jia", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Jean Parodo", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Monika Lodyga", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Andras Kapus", 2016, "Tyrosine phosphorylation of caspase-8 abrogates its apoptotic activity and promotes activation of c-Src"], ["Frank J Jacono", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Dalibor Kubelik", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Karen Burns", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Nathan Scales", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Christophe Herry", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Stephanie Godard", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Andrew JE Seely", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Samuel M Brown", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Paul Westergaard", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Donna E Maziak", 2016, "Practice variation in spontaneous breathing trial performance and reporting"], ["Lauralyn A McIntyre", 2016, "Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review"], ["Jeremy Grimshaw", 2016, "Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review"], ["Malcolm Mcleod", 2016, "Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review"], ["Michael A Rudnicki", 2016, "Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review"], ["Jason Fishman", 2016, "Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review"], ["P Joly", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["E Charbonney", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["Y Berthiaume", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["P Liaw", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["D Dwivedi", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["C Mass\u00e9", 2015, "DNA and sRAGE circulation in the early phase after polytrauma"], ["F Morriello", 2015, "Biomarkers in sepsis: a systematic review"], ["Andrew J Ferguson", 2015, "Fluid strategies and outcomes in patients with acute respiratory distress syndrome, systemic inflammatory response syndrome and sepsis: a protocol for a systematic review and \u2026"], ["Jonathan A Silversides", 2015, "Fluid strategies and outcomes in patients with acute respiratory distress syndrome, systemic inflammatory response syndrome and sepsis: a protocol for a systematic review and \u2026"], ["Paula Williamson", 2015, "Core Outcomes in Ventilation Trials (COVenT): protocol for a core outcome set using a Delphi survey with a nested randomised trial and observational cohort study"], ["Danny McAuley", 2015, "Core Outcomes in Ventilation Trials (COVenT): protocol for a core outcome set using a Delphi survey with a nested randomised trial and observational cohort study"], ["Daren K Heyland", 2015, "Pro biotics: Prevention of S evere P neumonia and E ndotracheal C olonization T rial\u2014PROSPECT: protocol for a feasibility randomized pilot trial"], ["Lehana Thebane", 2015, "Pro biotics: Prevention of S evere P neumonia and E ndotracheal C olonization T rial\u2014PROSPECT: protocol for a feasibility randomized pilot trial"], ["Noel Gibney", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Ryan Foster", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Susan Shaw", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Rob Green", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Andrea Hill", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Philip Abdelmalik", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Denise Foster", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["Natalie Bandrauk", 2015, "Critical care capacity in Canada: results of a national cross-sectional study"], ["C Martin", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["C Herry", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["S Godard", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["D Kubelik", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["N Scales", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["P Westergaard", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["K Burns", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["F Jacono", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["DE Maziak", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["S Brown", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["A Seely", 2015, "Practice variation in spontaneous breathing trial performance and documentation."], ["Steven G Simonson", 2015, "Talactoferrin in severe sepsis: results from the phase II/III oral talactoferrin in severe sepsis trial"], ["Kalpalatha Guntupalli", 2015, "Talactoferrin in severe sepsis: results from the phase II/III oral talactoferrin in severe sepsis trial"], ["Rajesh Malik", 2015, "Talactoferrin in severe sepsis: results from the phase II/III oral talactoferrin in severe sepsis trial"], ["R Phillip Dellinger", 2015, "Talactoferrin in severe sepsis: results from the phase II/III oral talactoferrin in severe sepsis trial"], ["Alex Strauss", 2015, "Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis"], ["Shirley Mei", 2015, "Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis"], ["Keith Walley", 2015, "Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis"], ["Duncan Stewart", 2015, "Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis"], ["Mazen Jasi", 2015, "Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis"], ["Simone E Birch", 2015, "Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation"], ["Menachem Ailenberg", 2015, "Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation"], ["Patrick S Tawadros", 2015, "Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation"], ["Kinga A Powers", 2015, "Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation"], ["Ori D Rotstein", 2015, "Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation"], ["J Wu", 2015, "The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival"], ["J Parodo", 2015, "The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival"], ["CM Lee", 2015, "The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival"], ["J Hu", 2015, "The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival"], ["Maureen O Meade", 2015, "Blood pressure targets for vasopressor therapy: a systematic review"], ["Frederick D\u2019Aragon", 2015, "Blood pressure targets for vasopressor therapy: a systematic review"], ["Matthias Briel", 2015, "Blood pressure targets for vasopressor therapy: a systematic review"], ["Pierre Asfar", 2015, "Blood pressure targets for vasopressor therapy: a systematic review"], ["Emilie P Belley-Cote", 2015, "Blood pressure targets for vasopressor therapy: a systematic review"], ["Randy Hollins", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Peter Clardy", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Annmarie Anderson", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Kristin Russell", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Kathryn Butler", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Michael Donnino", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Douglas J Hsu", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["Susan Holland", 2015, "Phenobarbital Versus Benzodiazepines For The Treatment Of Alcohol Withdrawal Syndrome In Critically Ill Patients"], ["George A Tomlinson", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Jill Rudkowski", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Andrea L Matte", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Susan Abbey", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Christie Lee", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Brian Cuthbertson", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Vince Lo", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Laurent J Brochard", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Staceu Burns", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Neill Adhikari", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Mary E Wilcox", 2015, "The RECOVER program: one-year disability in critically ill patients mechanically ventilated (MV) for 7 days"], ["Grace Christou", 2015, "Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic Review"], ["Marc Avey", 2015, "Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic Review"], ["Jeannie Callum", 2015, "Age of transfused blood in critically ill adults"], ["Helen Campbell", 2015, "Age of transfused blood in critically ill adults"], ["Morris A Blajchman", 2015, "Age of transfused blood in critically ill adults"], ["Dong Vo", 2015, "Age of transfused blood in critically ill adults"], ["Pierre Tiberghien", 2015, "Age of transfused blood in critically ill adults"], ["Nardo J Van Der Meer", 2015, "Age of transfused blood in critically ill adults"], ["Elham Sabri", 2015, "Age of transfused blood in critically ill adults"], ["Paul C H\u00e9bert", 2015, "Age of transfused blood in critically ill adults"], ["Alan Tinmouth", 2015, "Age of transfused blood in critically ill adults"], ["Lucy Clayton", 2015, "Age of transfused blood in critically ill adults"], ["Gilles Capellier", 2015, "Age of transfused blood in critically ill adults"], ["Jacques Lacroix", 2015, "Age of transfused blood in critically ill adults"], ["Laurent Bardiaux", 2015, "Age of transfused blood in critically ill adults"], ["Leo Van de Watering", 2015, "Age of transfused blood in critically ill adults"], ["Simon J Stanworth", 2015, "Age of transfused blood in critically ill adults"], ["A Tinmouth", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["L van de Watering", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["G Capellier", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["P Tiberghien", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["P H\u00e9bert", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["E Sabri", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["D Vo", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["H Campbell", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["T Walsh", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["S Stanworth", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["J Lacroix", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["L Clayton", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["N van der Meer", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["M Blajchman", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["J Callum", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["L Bardiaux", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["A Turgeon", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["D Cook", 2015, "Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults-The Age of Blood Evaluation (ABLE) Randomised Controlled Trial: S10"], ["Samuel Bederman", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["John Alverdy", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Dong Hu", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jaswin Sawhney", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Christopher Guidry", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Neal Shonnard", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Saad Salim", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Monika Krezalek", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Benjamin Kautza", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Nikolai Khodarev", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Zequan Yang", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Margaret McGuire", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["David Flum", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Katie Love", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jonathan Gates", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Xiao Yao", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Rod Oskouian Jr", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Mark Hamill", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Eric Bradburn", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jiselle Heaney", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Scott Christley", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Meihong Deng", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Arham Ali", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Robert Stovall", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["James Luo", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Reza Askari", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Allan Tsung", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Brandy Edwards", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Du Yuan", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Tina Mele", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Qun Zang", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jennifer DeFazio", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Clay Burlew", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Todd Costantini", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Rhett N Willis", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Bana Jabri", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Baddr Shakhsheer", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["E Patchen Dellinger", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Raul Coimbra", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Daryl Gray", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Andrew Stephen", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Derek Angus", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Hyunsu Ju", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Sydne Muratore", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Michael Lee", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Mary Kwaan", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Kristina Guyton", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Deborah Carlson", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["James Gwosdz", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Xiuwen Wu", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Olga Zaborina", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Gefei Wang", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Carlton Barnett", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Hai Huang", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Simone Langness", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["David Herndon", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["JJ Glover", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Ali Salim", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Richard Collage", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Rajiv Sethi", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Nour AlMalki", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Brandon Chapman", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Allan Peetz", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Ken Leslie", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Lynn Hancock", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Brian Zuckerbraun", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Gillian Abrams", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Anne Pugel", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Zara Cooper", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Sangman Kim", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Timothy Billiar", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Joaquim Havens", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Rachel Khadaroo", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Daithi Heffernan", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Robin Klabbers", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Sandy Fogel", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Stephanie Lueckel", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Arturo Rios Diaz", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Gregory Jurkovich", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Greg Beilman", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Puja M Shah", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Alison Smith", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Michael Connolly", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Ernest Moore", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Ronald Nichols", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Xianghong Zhang", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Alexander Zaborin", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Robert Sawyer", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Joseph Minei", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Neil Parry", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Gezzer Ortega", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Walter Biffl", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Song Liu", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Thomas Churchill", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Frederic Pieracci", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Olubode Olufajo", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Natalia Belogortseva", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Guosheng Gu", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Celeste Finnerty", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Kalvin Lung", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jeffrey Johnson", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Amy Cizik", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Sara Khor", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Greig McCreery", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Matthew Rosengart", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jennifer Salotto", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Benoit Herbert", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Melanie Scott", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Stephen Davies", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Maridi Rodil", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["David Tobin Harrington", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["William Cioffi", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Brian Eliceiri", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Catherine Statz", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Kinga Powers", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Bryan Collier", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Seth Goldstein", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Jianan Ren", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Christopher Baker", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Chris Vinden", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Varun Bhalla", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Charles Adams Jr", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Steven Wolf", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["James Korndorffer Jr", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Peter Lundberg", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Charles Fox", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Christopher Reed", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Zachary Dietch", 2015, "Program and Abstracts Thirty-fifth Annual Meeting of the Surgical Infection Society Westlake Village, California April 15\u201318, 2015"], ["Stefan Knapp", 2015, "Preclinical target validation using patient-derived cells"], ["Christopher Flores", 2015, "Preclinical target validation using patient-derived cells"], ["Andrew J Carr", 2015, "Preclinical target validation using patient-derived cells"], ["Kirk Clark", 2015, "Preclinical target validation using patient-derived cells"], ["Carolyn Buser-Doepner", 2015, "Preclinical target validation using patient-derived cells"], ["Valeria R Fantin", 2015, "Preclinical target validation using patient-derived cells"], ["Chas Bountra", 2015, "Preclinical target validation using patient-derived cells"], ["Saul H Rosenberg", 2015, "Preclinical target validation using patient-derived cells"], ["Ronan C O'hagan", 2015, "Preclinical target validation using patient-derived cells"], ["Christopher L Carpenter", 2015, "Preclinical target validation using patient-derived cells"], ["Ingrid E Lundberg", 2015, "Preclinical target validation using patient-derived cells"], ["Marc Feldmann", 2015, "Preclinical target validation using patient-derived cells"], ["Kevin Petrecca", 2015, "Preclinical target validation using patient-derived cells"], ["Rab K Prinjha", 2015, "Preclinical target validation using patient-derived cells"], ["Nada Jabado", 2015, "Preclinical target validation using patient-derived cells"], ["Dashyant Dhanak", 2015, "Preclinical target validation using patient-derived cells"], ["Alex E MacKenzie", 2015, "Preclinical target validation using patient-derived cells"], ["Dhavalkumar D Patel", 2015, "Preclinical target validation using patient-derived cells"], ["Dominique Verhelle", 2015, "Preclinical target validation using patient-derived cells"], ["Kym M Boycott", 2015, "Preclinical target validation using patient-derived cells"], ["Tetsuyuki Maruyama", 2015, "Preclinical target validation using patient-derived cells"], ["Jagdeep Nanchahal", 2015, "Preclinical target validation using patient-derived cells"], ["Paul Bowness", 2015, "Preclinical target validation using patient-derived cells"], ["Trevor Howe", 2015, "Preclinical target validation using patient-derived cells"], ["Catherine O'brien", 2015, "Preclinical target validation using patient-derived cells"], ["Panagiotis Prinos", 2015, "Preclinical target validation using patient-derived cells"], ["Evelyne Lima-Fernandes", 2015, "Preclinical target validation using patient-derived cells"], ["Senthil Muthuswamy", 2015, "Preclinical target validation using patient-derived cells"], ["Anuk M Das", 2015, "Preclinical target validation using patient-derived cells"], ["Mario H Bengtson", 2015, "Preclinical target validation using patient-derived cells"], ["Mark E Bunnage", 2015, "Preclinical target validation using patient-derived cells"], ["Phil Barker", 2015, "Preclinical target validation using patient-derived cells"], ["L Trevor Young", 2015, "Preclinical target validation using patient-derived cells"], ["Hans Widmer", 2015, "Preclinical target validation using patient-derived cells"], ["Cindy Bell", 2015, "Preclinical target validation using patient-derived cells"], ["Guy Rouleau", 2015, "Preclinical target validation using patient-derived cells"], ["Wen Hwa Lee", 2015, "Preclinical target validation using patient-derived cells"], ["Katlin B Massirer", 2015, "Preclinical target validation using patient-derived cells"], ["Per-Johan Jakobsson", 2015, "Preclinical target validation using patient-derived cells"], ["John TR Isaac", 2015, "Preclinical target validation using patient-derived cells"], ["James Ellis", 2015, "Preclinical target validation using patient-derived cells"], ["Udo Oppermann", 2015, "Preclinical target validation using patient-derived cells"], ["Donald E Frail", 2015, "Preclinical target validation using patient-derived cells"], ["Bruce G Pollock", 2015, "Preclinical target validation using patient-derived cells"], ["Michael Sundstr\u00f6m", 2015, "Preclinical target validation using patient-derived cells"], ["Cheryl H Arrowsmith", 2015, "Preclinical target validation using patient-derived cells"], ["Dalia Barsyte", 2015, "Preclinical target validation using patient-derived cells"], ["Viviane Poupon", 2015, "Preclinical target validation using patient-derived cells"], ["Aled M Edwards", 2015, "Preclinical target validation using patient-derived cells"], ["Anke Mueller-Fahrnow", 2015, "Preclinical target validation using patient-derived cells"], ["Peter Dirks", 2015, "Preclinical target validation using patient-derived cells"], ["Malcolm Skingle", 2015, "Preclinical target validation using patient-derived cells"], ["Edward A Fon", 2015, "Preclinical target validation using patient-derived cells"], ["Lars Klareskog", 2015, "Preclinical target validation using patient-derived cells"], ["Garth AM Smith", 2015, "Preclinical target validation using patient-derived cells"], ["Nils Ostermann", 2015, "Preclinical target validation using patient-derived cells"], ["Julian C Knight", 2015, "Preclinical target validation using patient-derived cells"], ["Michael D Taylor", 2015, "Preclinical target validation using patient-derived cells"], ["Opher Gileadi", 2015, "Preclinical target validation using patient-derived cells"], ["Yuhang Ai", 2015, "Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells"], ["Qianyi Peng", 2015, "Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells"], ["S Gallagher", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["R Certain", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["C Betzler", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Bartholomew", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["E Gischler", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Holbourn", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["K F\u00f6llmi", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["I Bucur", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["L Krystyn", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Langer", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["N Chow", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["Y Kuester", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["C Cowan", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Bellian", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Bergstr\u00f6m", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["G Boschian", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["F F\u00fcrsich", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Holland", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Bannikov", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["L Melim", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["K Krainer", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Gocke", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Gradzinski", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["R Martini", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["CA Hasler", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P Kench", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["F Gregory", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Hetzinger", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Fontana", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["G Fr\u00e9bourg", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["N Ishida", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Carmichael", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["H Luterbacher", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["B Granier", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Halfar", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Chiari", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["F Maurer", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["C Laughrey", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P K\u00f6nigshof", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["AV Bojar", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Kov\u00e1c", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P Koeniger", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Elrick", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Blau", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Brandano", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Dominici", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["D Lehrmann", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["C Dupraz", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P Cozar", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Gregg", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["WC Dullo", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["R Hori", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Haas", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["T Algeo", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Cherchi", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["C Chira", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Jasionowski", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Calonge", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Freiwald", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["E Gierlowski-Kordesch", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["H Keupp", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Bernecker", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Kalvoda", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Mancini", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["HJ Gawlick", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P Kindler", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Calner", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["D Knaust", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Lokier", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["G Heiss", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["F Barattolo", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P Boggiani", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["H Bonab", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["R H\u00f6fling", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["E Davaud", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["M Maldonaldo", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["A Luz\u00f3n", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["HJ Kuss", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["P McLaughlin", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["D Dias-Brito", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["D Bower", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["G Carnevale", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["J Hohenegger", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Gorican", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["EA Jagniecki", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["S Kershaw", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["D Cantrell", 2015, "The Editors and the Editorial office would like to thank all Board members and the many other scientists who helped us in reviewing manuscripts in 2014 and thus contributed to \u2026"], ["LA McIntyre", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["J Grimshaw", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["G Christou", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["M Mcleod", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["SHJ Mei", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["KJ Sullivan", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["J Fishman", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["M Avey", 2015, "A57 LUNG INJURY, REPAIR, AND FIBROSIS: THE PLOT THICKENS FOR THREE'S COMPANY: Mesenchymal Stromal Cell Therapy For Acute Lung Injury In Preclinical Animal Models: A Systematic \u2026"], ["C Lee", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["L Singer", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["AS Slutsky", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["J Flannery", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["N Ayas", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["H Meggison", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["J Rudkowski", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["S Mathur", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["Y Skrobik", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["C Chaparro", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["LJ Brochard", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["S Abbey", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["MS Herridge", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["ME Wilcox", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["P Hebert", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["AL Matte", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["P Robles", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["DC Scales", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["ND Ferguson", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["A Tan", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["S Burns", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["J Cameron", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["M Parotto", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["M Cypel", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["T Sinuff", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["B Cuthbertson", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["R Fowler", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["S Keshavjee", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["L Flockhart", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["GD Rubenfeld", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["L Rose", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["N Adhikari", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["V Lo", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["M Bayley", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["GA Tomlinson", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["CW Chow", 2015, "C94 HIGH IMPACT CLINICAL TRIALS IN CRITICAL CARE: The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days"], ["Lauralyn Mcintyre", 2015, "The Effect of Inadequate Initial Antimicrobial Treatment on Mortality in Critically Ill Patients With Bloodstream Infections"], ["Sean Bagshaw", 2015, "The Effect of Inadequate Initial Antimicrobial Treatment on Mortality in Critically Ill Patients With Bloodstream Infections"], ["Rachel Savage", 2015, "The Effect of Inadequate Initial Antimicrobial Treatment on Mortality in Critically Ill Patients With Bloodstream Infections"], ["Tom Stelfox", 2015, "The Effect of Inadequate Initial Antimicrobial Treatment on Mortality in Critically Ill Patients With Bloodstream Infections"], ["Asgar Rishu", 2015, "The Effect of Inadequate Initial Antimicrobial Treatment on Mortality in Critically Ill Patients With Bloodstream Infections"]]}